Larson Financial Group’s Insys Therapeutics, Inc. INSY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-361
Closed -$2K 600
2019
Q1
$2K Hold
361
﹤0.01% 404
2018
Q4
$1K Buy
+361
New +$2.51K ﹤0.01% 464

Other funds holding INSY

Larson Financial Group's INSY Position: Q2 2019 in Review

Larson Financial Group sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 361 shares — an estimated $2K sold.

Larson Financial Group first reported a position in INSY in Q4 2018 and held it in 2 quarters. The position peaked at $2K in Q1 2019. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Larson Financial Group reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Larson Financial Group sold 361 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $2K.
  • Larson Financial Group first reported a position in Insys Therapeutics, Inc. in Q4 2018 and held it in 2 quarters.
  • Larson Financial Group's Insys Therapeutics, Inc. position peaked at $2K in Q1 2019.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Larson Financial Group's 13F filing for Q2 2019, filed 16 Jul 2019.